Table 1.
Article | Study Design | Population | Outcome Measures |
---|---|---|---|
Zárate, S.C. et al. (2019) [50] | In vivo study | Rat | Neuroprotective effect of humanin and relationship with ovarian hormones |
Yen, K. et al. (2018) [38] | In vitro and in vivo study | SH-SY5Y cells, Mouse |
Neuroprotective effect of humanin |
Yen, K. et al. (2020) [40] | In vivo study |
C. elegans, Mouse, Human |
Circulating levels of humanin and their relation to diseases of aging and lifespan |
Gong, Z. et al. (2022) [49] |
Review | Mouse, Porcine |
Protective effect of humanin in myocardial ischemia-reperfusion. |
Kim, S.J. et al. (2021) [37] | Review | N/A | Humanin in age-related disease |
Gong, Z. et al. (2014) [51] |
Review | N/A | Role of humanin in age-related disease |
Caso, V.M. et al. (2021) [42] | In vitro study |
N/A | Neuroprotective effects of humanin and its homologs (HNG) from Aβ |
Zacharias, D.G. et al. (2012) [43] | In vivo study | Mouse | Humanin reduced plaque accumulation in Alzheimer’s disease and has a cytoprotective action in stroke |
Park, T. et al. (2013) [55] | In vivo study | Middle-aged APPswe/PS1dE9 mice | Treatment with HNG significantly improves spatial learning and memory deficits, reduces Aβ plaque accumulation and insoluble Aβ concentration; decreases neuro-inflammatory responses |